Most Read Articles
Tristan Manalac, Yesterday
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
4 days ago
Use of proton pump inhibitors (PPIs), even at higher cumulative levels, does not increase the risk for dementia, a recent study has shown.
11 Feb 2018
In males with primary or secondary hypogonadism (HG), adherence to topical testosterone therapy (TTh) appears to improve total testosterone and decrease the risk of conditions associated with HG, a recent study has shown.
6 days ago
Short-term treatment with methotrexate at >0.5 defined daily dose (8.75 mg/week) may help reduce the risk of ischaemic stroke in rheumatoid arthritis (RA) patients, while hydroxychloroquine and sulfasalazine have neutral effects, a retrospective study has found.

Mindfulness-based intervention improves depressive symptoms in girls at risk of T2D

15 Jul 2017
A look at high expectations and children’s well-being: Singapore

A mindfulness-based intervention is acceptable, feasible and more effective than cognitive-behavioural programmes in reducing depressive symptoms in girls with depressive symptoms and at risk of type 2 diabetes (T2D), reveals a new study.

The study included 33 overweight or obese female adolescents with mild to moderate depressive symptoms randomized to receive either the mindfulness-based intervention (n=17; mean age 15.01±1.68 years) or cognitive-behavioural therapy (n=16; mean age 14.97±1.75 years).

Mindfulness, measured by the Mindful Attention Awareness Scale (MAAS), improved in the mindfulness intervention group both at post-treatment (0.87±0.22) and at 6 months (0.83±0.23).

Similar increases, although smaller in magnitude, were observed in the cognitive-behavioural therapy group at post-treatment (0.56±0.20) and at 6 months (0.79±0.21).

Depressive and anxiety symptoms in the mindfulness intervention group were reduced at post-treatment (-11.34±1.36 and -5.37±1.34, respectively) and at 6 months (-8.25±1.67 and -6.39±1.33, respectively).

Decreases in depressive and anxiety symptoms were also observed at post-treatment (-7.45±1.35 and -4.45±1.30, respectively) and at 6 months (-8.25±1.67 and -6.39±1.33, respectively) in the cognitive-behavioural group, but the reductions were lower in magnitude compared with that achieved with the mindfulness intervention.

Post-treatment reductions in fasting insulin levels for the mindfulness intervention group were significantly greater than in the cognitive-behavioural therapy group. Levels for the two groups at 6 months (p=0.34) were not significantly different.

Acceptability was high and was not significantly different between the two groups.

Selected participants were at high risk of T2D and were received either cognitive-behavioural therapy or mindfulness therapy, which included interactive activities and discussions to improve mindfulness in participants.

Editor's Recommendations
Most Read Articles
Tristan Manalac, Yesterday
Of the newly identified genetic loci for primary angle-closure glaucoma (PACG), two are significantly associated with primary angle-closure suspect (PACS), indicating involvement in the earlier stages of the disease, a recent Singapore study has shown.
4 days ago
Use of proton pump inhibitors (PPIs), even at higher cumulative levels, does not increase the risk for dementia, a recent study has shown.
11 Feb 2018
In males with primary or secondary hypogonadism (HG), adherence to topical testosterone therapy (TTh) appears to improve total testosterone and decrease the risk of conditions associated with HG, a recent study has shown.
6 days ago
Short-term treatment with methotrexate at >0.5 defined daily dose (8.75 mg/week) may help reduce the risk of ischaemic stroke in rheumatoid arthritis (RA) patients, while hydroxychloroquine and sulfasalazine have neutral effects, a retrospective study has found.